Top Medical News from Across Medscape

  • 'MAP' Program Improves Hypertension ControlThe MAP program focuses on an accurate BP, intensifying treatment when an elevated BP is confirmed, and partnering with the patient to select and carry out the treatment plan.
  • FDA Approves Trelegy Ellipta for COPDThe FDA has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta, GlaxoSmithKline) for patients with COPD.
  • AAP Offers First Guidance on Tattoos, PiercingsThe report from the American Academy of Pediatrics (AAP) is designed to facilitate conversations between providers, parents, and patients about the increasingly common desire for body modifications.
  • Standards for Upper GI Endoscopy ReleasedThe BSG and AUGIS jointly released recommendations to improve the quality of upper gastrointestinal endoscopy and reduce the risk for missed early cancerous lesions.

Special Report

  • Healthcare policy is the number one topic -- not just in Washington, DC but in hospitals, medical practices, and homes. With so much happening on so many fronts, it's hard to keep up. Let us do it for you.

Business of Medicine

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California